Global Market News

NCATS inks drug-screening partnership with Lilly

3/13/2012

The drug company Eli Lilly will screen more than 3,800 approved and investigational medicines to find potential new uses for the drugs in a partnership with the US National Center for Advancing Translational Sciences (NCATS).

For more information, click here.

Return to Previous Page